Celiac Support Association

Celimmune Celiac Research Update - 

March 1, 2016 Celimmune’s Phase 2 AMG 714 clinical study in refractory celiac disease Type II (RCD-II) will be recruiting soon! To link directly to the clinical trial study use the identifier NCT02633020.  

Information to participate in Celiac Clinical Studies click here

Amazon Logo
Celimmune Celiac Research Update - Content Section 1 (ID:2373)